Insights into the binding of the drugs diclofenac sodium and cefotaxime sodium to serum albumin: Calorimetry and spectroscopy

European Journal of Pharmaceutical Sciences

Volumn 46, Issue 5, 2012, Pages 435-445

  Sharma, Ruchika ^a   Choudhary, Sinjan ^a   Kishore, Nand ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Binding thermodynamics; Bovine serum albumin; Calorimetry; Cefotaxime; Diclofenac; Spectroscopy

Indexed keywords

ANIONIC SURFACTANT; CATIONIC SURFACTANT; CEFOTAXIME; DICLOFENAC; SERUM ALBUMIN;

ARTICLE; BINDING AFFINITY; CALORIMETRY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BINDING; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG STABILITY; ENTHALPY; FLUORESCENCE SPECTROSCOPY; IONIC STRENGTH; ISOTHERMAL TITRATION CALORIMETRY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPECTROSCOPY; STEADY STATE; THERMODYNAMICS; TIME RESOLVED FLUORESCENCE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING SITES; CALORIMETRY, DIFFERENTIAL SCANNING; CEFOTAXIME; CIRCULAR DICHROISM; DICLOFENAC; DRUG INTERACTIONS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, CHEMICAL; OSMOLAR CONCENTRATION; PROTEIN BINDING; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; STATIC ELECTRICITY; SURFACE-ACTIVE AGENTS; TEMPERATURE; THERMODYNAMICS;

EID: 84861187788     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.03.007     Document Type: Article

References (48)

1. F. Barcelo, and J. Portugal Elsamicin A binding to DNA; a comparative thermodynamic characterization FEBS Lett. 576 2004 68 72
2. C. Briand, M. Sarrazin, R. Peyrot, M. Bourdeaux, and J.C. Sari Study of the interaction between human serum albumin and some cephalosporins Mol. Pharmacol. 21 1982 92 99
3. R. Brodersen, B. Honore, A.O. Pedersen, and I.M. Klotz Binding constants for ligand-carrier complexes Trends Pharmacol. Sci. 9 1988 252 257
4. R.N. Brogden, R.C. Heel, G.E. Pakes, T.M. Speight, and G.S. Avery Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin Drugs 20 1980 24 48
5. D.C. Carter, and J.X. Ho Structure of serum albumin Adv. Prot. Chem. 45 1994 153 203
6. F. Catella-Lawson, M.P. Reilly, and S.C. Kapoor Cyclooxygenase inhibitors and the antiplatelet effects of aspirin New Eng. J. Med. 345 2001 1809 1817
7. J.M. Chamouard, J. Barre, S. Urien, G. Houin, and J.P. Tillement Diclofenac binding to albumin and lipoproteins in human serum Biochem. Pharmacol. 34 1985 1695 1700
8. S.K. Dutta, S.K. Basu, and K.K. Sen Binding of diclofenac sodium with bovine serum albumin at different temperature, pH and ionic strength Indian J. Exp. Biol. 44 2006 123 127
9. M.R. Eftink, and C.A. Ghiron Fluorescence quenching of indole and model micelle systems J. Phys. Chem. 80 1976 486 493
10. K.J. Fehske, W.E. Muller, and U. Wollert The location of drug binding sites in human serum albumin Biochem. Pharmacol. 30 1981 687 692
11. E.L. Gelamo, and M. Tabak Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 56A 2000 2255 2271
12. E.L. Gelamo, C.H.T.P. Silva, H. Imasato, and M. Tabak Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modeling Biochim. Biophys. Acta 1594 2002 84 99
13. R.N. Goldberg, N. Kishore, and R.M. Lennen CRC Handbook of Chemistry and Physics D.R. Lide, 83rd ed 2002 CRC Press Boca Raton, FL 7:12 7:14
14. X.M. He, and D.C. Carter Atomic structure and chemistry of human serum albumin Nature 358 1992 209 215
15. J. Jackobson Binding of bilirubin to human serum albumin: determination of the dissociation constants FEBS Lett. 5 1969 112 114
16. F. Jobin, and F.T. Gagnon Inhibition of human platelet aggregation by a dibenzazepine compound (GP 44296) and by N-(2,6-dichlorophenyl)-o- aminophenylacetic acid(GP 45840) Can. J. Physiol. Pharmacol. 49 1971 479 481
17. V. Joly, B. Pangon, N. Brion, J.M. Vallois, and C. Carbon Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac J. Pharm. Exp. Ther. 246 1988 695 700
18. B.P. Kamat, and J. Seetharamappa Study of the interaction between fluoroquinolones and bovine serum albumin J. Chem. Sci. 11 2005 649 655
19. I.M. Kenawi, B.N. Barsoum, and M.A. Youssef Drug-drug interaction between diclofenac, cetirizine and ranitidine J. Pharm. Biomed. Anal. 37 2005 655 661
20. I.M. Kenawi DFT analysis of diclofenac activity and cation type influence on the theoretical parameters of some diclofenac complexes J. Mol. Struct.: Theochem 761 2006 151 157
21. U. Kragh-Hansen, F. Hellec, B.D. Foresta, M.L. Maire, and J.V. Moller Detergents as probs of hydrophobic binding cavities in serum albumin and other water soluble proteins Biophys. J. 80 2001 2898 2911
22. N.A. Kratochwil, W. Huber, F. Muller, M. Kansy, and P.R. Gerber Predicting plasma protein binding of drugs: a new approach Biochem. Pharmacol. 64 2002 1355 1374
23. S.S. Lehrer Solute perturbation of protein fluorescence: the quenching of the tryptophan fluorescence of model compounds and lysozyme by iodide ion Biochemistry 10 1971 3254 3263
24. O. Lopez, A. de la Maza, L. Coderch, C. Lopez-Iglesias, E. Wehrli, and J.L. Parra Direct formation of mixed micelles in the solubilization of phospholipid liposomes by Triton X-100 FEBS Lett. 426 1998 314 318
25. Y. Maitani, M. Nakagaki, and T. Nagai Determination of the acid dissociation constants in ethanol-water mixtures and partition coefficients for diclofenac Int. J. Pharm. 74 1991 105 116
26. G.L. Mandell, and M.A. Sande A.G. Gilman, T.W. Rale, A.S. Nies, P. Taylor, Goodman and Gilman's the pharmacological basis of therapeutics eighth ed. 1990 Pergamon Press New York 1065 1097
27. M.N. Markovich, and E.V. Avereva Microcalorimetry study of pharmacological complexes. The binding of cephalosporins with human serum albumin Antibiot. Med. Biotechnol. 30 1985 916 918
28. M.I. Marks Bacterial meningitis: an update Clin. Pediatr. 30 1991 673 675
29. R.E. Maurice, and A.G. Camillo Fluorescence quenching studies with proteins Anal. Biochem. 114 1981 199 212
30. P. McNamara, V. Treub, and K. Stoeckel Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam Biochem. Pharmacol. 40 1990 1247 1253
31. P. Moser, A. Sallmann, and I. Wiesenberg Synthesis and quantitative structure-activity relationships of diclofenac analogues J. Med. Chem. 33 1990 2358 2368
32. W.E. Muller, and U. Wollert Human serum albumin as a 'silent receptor' for drugs and endogenous substances Pharmacology 19 1979 59 67
33. B. Nerli, D. Romanini, and G. Pico Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin Chem. Biol. Interact. 104 1997 179 202
34. M.E. Palomo, M.P. Ballesteros, and P. Frutos Analysis of diclofenac sodium and derivatives J. Pharm. Biomed. Anal. 21 1999 83 94
35. A. Papadopoulou, R.J. Green, and R.A. Frazier Interaction of flavonoids with bovine serum albumin: a fluorescence quenching study J. Agric. Food Chem. 53 2005 158 163
36. T. Peters Jr. All About Albumin 1996 Acad. Press San Diego
37. M.H. Rahman, K. Yamasaki, Y.H. Shin, C.C. Lin, and M. Otagiri Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin Biol. Pharm. Bull. 16 1993 1169 1174
38. M.T. Record, C.F. Anderson, and T.M. Lohman Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening and ion effects on water activity FEBS Lett. 11 1978 103 178
39. B. Rocca, and G. Petrucci Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms Thrombosis 2012 2012 1 11
40. I. Sjoholm, B. Ekman, A. Kober, I.L. Pahlman, B. Seiving, and T. Sjodin Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles Mol. Pharmacol. 16 1979 767 777
41. H.A. Sober, and R.A. Harte second ed. 1973 CRC Press Cleveland, OH C-71
42. G. Sudlow, D.J. Birkett, and D.N. Wade The characterization of two specific drug binding sites on human serum albumin Mol. Pharmacol. 11 1975 824 834
43. G. Sudlow, D.J. Birkett, and D.N. Wade Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12 1976 1052 1061
44. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi Crystal structure of human serum albumin at 2.5 A resolution Protein Eng. 12 1999 439 446
45. K. Takeda, M. Shigeta, and K. Aoki Secondary structures of bovine serum albumin in anionic and cationic surfactant solutions J. Colloid Interface Sci. 117 1987 120 126
46. S. Tawara, S. Matsumoto, Y. Matsumoto, T. Kamimura, and S. Goto Structure binding relationship and binding sites of cephalosporins in human serum albumin J. Antibiot. 45 1992 1346 1357
47. E. Tsivou, I. Melakopoulos, A. Kotsiou, S. Anagnostopoulou, and C. Tesseromatis Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen Eur. J. Drug Metab. Pharmacokinet. 30 2005 171 174
48. M.X. Xie, X.Y. Xu, and Y.D. Wang Interaction between hesperetin and human serum albumin revealed by spectroscopic methods Biochim. Biophys. Acta 1724 2005 215 224